Table 1.
Strain | Model | Day | Tissue evaluation | Plasma evaluation | n |
---|---|---|---|---|---|
TFflox/flox ,LysMCre+ | TC | 0 | qRT-PCR & TW | 6 | |
Vein Wall Morphometrics | D-dimer | 5 | |||
EIM | 2 | qRT-PCR & TW | 10 | ||
Vein Wall Morphometrics | D-dimer | 10 | |||
EIM | 6 | qRT-PCR & TW | 10 | ||
Vein Wall Morphometrics | D-dimer | 10 | |||
TFf lox/f lox ,LysMCre- | TC | 0 | qRT-PCR & TW | 6 | |
Vein Wall Morphometrics | D-dimer | 3 | |||
EIM | 2 | qRT-PCR & TW | 10 | ||
Vein Wall Morphometrics | D-dimer | 3 | |||
EIM | 6 | qRT-PCR & TW | 10 | ||
Vein Wall Morphometrics | D-dimer | 3 | |||
C57BL/6 TF antibody 1H1 | EIM | 2 | qRT-PCR & TW | 10 | |
EIM | 6 | qRT-PCR & TW | 5 | ||
C57BL/6 IgG Controls | EIM | 2 | qRT-PCR & TW | 10 | |
EIM | 6 | qRT-PCR & TW | 5 |